Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 14.40
-0.58 (-3.87%)
Jun 2, 2026, 3:00 PM CST
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 6.06 billion as of June 2, 2026. Its market cap has increased by 20.50% in one year.
Market Cap
6.06B
Enterprise Value
6.36B
Revenue
699.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.40
Market Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 6.06B, a decrease of -53.34%. That is a compound annual growth rate of -12.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.06B | -11.82% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 7.61B |
| Innovita Biological Technology | 7.36B |
| Acrobiosystems | 6.78B |
| Xiangxue Pharmaceutical | 6.56B |
| Suzhou Fengbei Biotech Stock | 6.32B |
| Chengdu Kanghua Biological Products | 6.20B |
| Wuhan Keqian Biology Co.,Ltd | 6.10B |
| Shanghai OPM Biosciences | 6.07B |